Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Morgan Stanley kept Apple as its "Top Pick" for 2025 as the bank sees the tech giant's artificial intelligence (AI) product ...

The stock's fall snapped a two-day winning streak.

Sempra (NYSE:SRE) +1.5% in Friday's trading as Morgan Stanley upgrades to Overweight from Equal Weight with a $98 price ...

Could Google lose its dominance to artificial intelligence powered startups?  Will the new Department of Government ...

Morgan Stanley is close to an agreement to buy around €900 million ($940 million) in Spanish mortgages from Banco Santander ...

Nomura Holdings Inc. and Morgan Stanley are set to launch currency market-making services in India, according to people ...

Betsy Graseck, Morgan Stanley global head of banks and diversified finance research, joins 'Squawk Box' to discuss the ...

Morgan Stanley analyzes potential impacts of TikTok ban on tech and retail companies, highlights potential beneficiaries and ...

Morgan Stanley Smith Barney will pay a $15 million penalty as part of a settlement with the Securities and Exchange ...

Tesla stock surged to an all-time high Tuesday after Morgan Stanley analyst Adam Jonas increased his price target for the ...

Morgan Stanley analyst Erik Woodring notes that Apple (AAPL) has outperformed the S&P 500 by 10 points over the last month and shares are ...